Search results for “Cyclin-dependent kinase complex” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 30 patents, we discovered top 12 key players by total patent application. Novartis AG, Astex Therapeutics Ltd., Bristol-Myers Squibb Pharma Co. are dominant in this area. They take 53.33% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 5
Astex Therapeutics Ltd.
Cambridgeshire, United Kingdom
Patent: 5
Bristol-Myers Squibb Pharma Co.
New York, United States
Patent: 3
Cancer Research Ventures Ltd.
United Kingdom
Patent: 3
Industrial Research Ltd.
WELLINGTON, New Zealand
Patent: 2
Bristol Myers Squibb Co.
New York, United States
Patent: 1
Piramal Enterprises Ltd.
Maharashtra, India
Patent: 1
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1
Targeted Growth, Inc.
Washington, United States
Patent: 1
Boehringer Ingelheim Pharma GmbH
Austria
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Jiangnan University
Jiangsu Sheng, China
Patent: 1
Tokyo University of Agriculture
Tokyo-to, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: